"Centro de diagnóstico por imágenes, realizamos estudios de resonancia magnética abierta, de alto campo y de 3 Teslas. Además ofrecemos tomografía espiral multicorte y Fibroscan. 25 años de experiencia."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Clinical Trials at Resocentro
During the past decade, Resocentro conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
2014-09-30
2018-04-19
Completed
394
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Resocentro
According to Clinical.Site data, the most researched conditions in "Resocentro" are
"Follicular Lymphoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Resocentro" in a lesser frequency.
Clinical Trials Intervention Types at Resocentro
Most popular intervention types in "Resocentro" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Herceptin®" (1 trials), "MabThera®" (1 trials), "PF-05280014" (1 trials), "PF-05280586" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Resocentro
The vast majority of trials in "Resocentro" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Resocentro
Currently, there are NaN active trials in "Resocentro".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Resocentro,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Resocentro, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".